DocDollars

Spineart SA

Switzerland · Reporting entity ID 100000151619

Total reported 2019–2025
$20.2M
#313 of 2,960 reporting companies — 0% of all reported industry payments
$11.7M in general payments across 865 records, plus $8.28M in research funding across 458 records.

How it breaks down

General payments $11,727,879
Research funding $8,281,480
Ownership & investment $214,000

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Spineart SA reported $20.2M to US doctors and teaching hospitals from 2019 to 2025, ranking #313 of 2,960 reporting companies. 41% of that was research funding and 59% general payments such as consulting, speaking, food and travel. 865 general payment records and 458 research records were filed.

Common questions about Spineart SA

How much has Spineart SA paid US doctors?

Spineart SA reported $20,223,359 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $11,727,879 in general payments, $8,281,480 in research funding and $214,000 in ownership and investment interests.

How does Spineart SA rank among drug and device companies?

It ranks #313 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Spineart SA mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.